Literature DB >> 23268394

[Effect of atorvastatin on eNOS synthesis in organs of aging rats with myocardial ischemia-reperfusion].

Jinyao Zhang1, Hao Wang, Ping Ye.   

Abstract

OBJECTIVE: To observe the effect of atorvastatin on eNOS synthesis in the vital organs of aging rats and explore its mechanism for protection against myocardial ischemia-reperfusion injury.
METHODS: Twenty-month-old Wistar rats were given daily atorvastatin lavage for 4 months. Myocardial ischemia-reperfusion model was established by ligating the coronary artery. The rats were randomized into normal control group, untreated model group, medication without surgery group, and atorvastatin-treated surgical group. The content of eNOS in the heart, liver and kidneys was detected by Western blotting, and eNOS mRNA expression by RT-PCR. The effects of different doses of atorvastatin on eNOS expressions were also evaluated.
RESULTS: Atorvastatin significantly promoted eNOS synthesis in the heart, liver and kidney of the rats (P<0.05) regardless of myocardial ischemia-reperfusion. A higher dose of atorvastatin caused a more obvious increase of eNOS protein and mRNA expression in the vital organs of the aging rats (P<0.05).
CONCLUSION: Atorvastatin can increase eNOS synthesis in the vital organs of aging rats, which partially explains the organ-protective effect of atorvastatin against myocardial ischemia- reperfusion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23268394

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  2 in total

Review 1.  Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Saeideh Hajighasemi; Maciej Banach; Peter E Penson; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  J Clin Med       Date:  2019-11-22       Impact factor: 4.241

Review 2.  Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications.

Authors:  Armita Mahdavi Gorabi; Nasim Kiaie; Matteo Pirro; Vanessa Bianconi; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.